ClinVar Miner

Submissions for variant NM_024665.7(TBL1XR1):c.1192A>T (p.Lys398Ter)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Wasik Lab, Fox Chase Cancer Center RCV003317985 SCV004020300 likely pathogenic Malignant lymphoma, large B-cell, diffuse 2023-07-25 no assertion criteria provided clinical testing This variant was observed in a patient with DLBCL that presented in leukemic form, best classified as MCD/C5 DLBCL, an ABC subtype. Despite an initial good clinical response to BTK inhibitor ibrutinib, anti-CD20 antibody rituxan, alkylating agent bendamustine, and hematopoietic stem-cell transplant, the lymphoma relapsed, accompanied by morphologic and molecular evidence of disease progression. TBL1XR1 K398* and Y446C were detected in the tumor at presentation and after recurrence, with the K398* allele frequency doubling from 30% to 60%. These TBL1XR1 alterations result in the loss of interaction of the SMRT/NCOR1 complex with the germinal center transcriptional repressor BCL-6. Instead, BCL-6 binding to the transcription factor BACH2 complex is induced. This binding realignment blocks germinal-center B cells from developing into plasma cells by repressing PRDM1, a transcriptional repressor. Additionally, at relapse, this tumor had arm-level loss of 6q which contains PRDM1. Inactivation of PRDM1 is critical to pathogenesis of ABC-DLBCL (Pasqualucci et al. 2006; Calado et al. 2010; Mandelbaum et al. 2010). Collectively, TBL1XR1 mutations and loss of PRDM1 prevent B-cell differentiation towards plasma cells and drive them toward the memory B-cell program (Venturutti and Melnick 2020; Venturutti et al. 2020), most likely contributing to malignant cell transformation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.